Literature DB >> 26092172

Amyloid fibril formation from a 9 amino acid peptide, 55th-63rd residues of human lysozyme.

Yuhei Tokunaga1, Mitsuharu Matsumoto2, Yasushi Sugimoto3.   

Abstract

Hen egg white lysozyme (HEWL) readily forms amyloid fibrils in vitro. We have previously identified a core structure, termed HEWL K-peptide, involved in fibril formation. Two major peptides, peptide #3 (50th-102nd residues of human lysozyme (hLZ)) and peptide #5 (54th-102nd residues), were isolated from the hLZ amyloid fibrils that had been exposed to pH 2.0 and 58 °C, and precipitated by ultra-centrifugation. These peptides cover most of the beta-domain and C-helix of hLZ including a 9 residues sequence corresponds to a human counterpart of HEWL K-peptide, GIFQINSRY (55th-63rd residues of hLZ, thus named "human K-peptide"). Chemically synthesized human K-peptide readily formed amyloid fibrils, as in HEWL K-peptide. It was demonstrated that both at least 9 residue length and Phe residue at 3rd position of the human K-peptide were crucial for amyloidogenesis in vitro. Short peptides covering COOH-terminal region of peptides #3 and #5 did not form amyloid fibrils. These data suggested that human K-peptide region with high propensity of amyloidogenesis plays a key role as a fibril-forming core sequence of hLZ. Interestingly, human K-peptide region is flanked by two predicted semi-disordered regions (39th-52nd and 67th-75th residues). We discuss the possible role of these regions.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acid hydrolysis; Amyloid fibril; Core peptide; Hen egg white lysozyme; Human lysozyme; β-Structure

Mesh:

Substances:

Year:  2015        PMID: 26092172     DOI: 10.1016/j.ijbiomac.2015.06.015

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  1 in total

1.  Lysozyme Mutants Accumulate in Cells while Associated at their N-terminal Alpha-domain with the Endoplasmic Reticulum Chaperone GRP78/BiP.

Authors:  Yoshiki Kamada; Yusuke Nawata; Yasushi Sugimoto
Journal:  Int J Biol Sci       Date:  2016-01-01       Impact factor: 6.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.